These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 492427

  • 1. Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure.
    Ksiazek A.
    Nephron; 1979; 24(4):170-3. PubMed ID: 492427
    [Abstract] [Full Text] [Related]

  • 2. [Plasma catecholamine concentration and plasma dopamine-beta-hydroxylase activity in patients undergoing chronic hemodialysis (author's transl)].
    Sakuma H, Miura Y, Kobayashi K, Tomioka H, Adachi M, Furuyama T, Yoshinaga K, Sekino H, Ishizaki T.
    Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):753-62. PubMed ID: 7206334
    [No Abstract] [Full Text] [Related]

  • 3. Plasma norepinephrine and dopamine-beta-hydroxylase activity in chronic renal failure.
    Ban M, Matsuno T, Ogawa K, Satake T.
    Jpn Circ J; 1979 Jul; 43(7):627-32. PubMed ID: 501895
    [Abstract] [Full Text] [Related]

  • 4. Variable levels of plasma catecholamines and dopamine beta-hydroxylase in hemodialysis patients.
    Corder CN, Sharma J, McDonald RH.
    Nephron; 1980 Jul; 25(6):267-72. PubMed ID: 6993966
    [Abstract] [Full Text] [Related]

  • 5. [The function of the sympathetic nervous system determined by humoral factors in the maintenance hemodialysis patients].
    Minami M, Sano M, Saito I, Yamazaki N, Togashi H, Yoshioka M, Saito H, Kawaguchi M.
    Hokkaido Igaku Zasshi; 1986 Mar; 61(2):186-94. PubMed ID: 3721395
    [Abstract] [Full Text] [Related]

  • 6. Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure.
    Minami M, Yasuda H, Yamazaki N, Kojima S, Nishijima H, Matsumura N, Togashi H, Koike Y, Saito H.
    Circulation; 1983 Jun; 67(6):1324-9. PubMed ID: 6851028
    [Abstract] [Full Text] [Related]

  • 7. Plasma norepinephrine, epinephrine, and dopamine levels in end-stage renal disease. Effect of hemodialysis.
    Elias AN, Vaziri ND, Maksy M.
    Arch Intern Med; 1985 Jun; 145(6):1013-5. PubMed ID: 4004425
    [Abstract] [Full Text] [Related]

  • 8. Plasma dopamine-beta-hydroxylase in uremia--increase in enzyme activity after renal transplantation.
    Wang DM, Sasse EA, Itskovitz HD, Piering WF, Kochar MS, Doumas BT.
    Clin Chim Acta; 1980 Feb 28; 101(2-3):241-9. PubMed ID: 6987013
    [Abstract] [Full Text] [Related]

  • 9. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
    Wocial B, Januszewicz W, Siedlecki I, Feltynowski T, Debiński W.
    Endokrinologie; 1982 Feb 28; 79(1):131-9. PubMed ID: 7084126
    [Abstract] [Full Text] [Related]

  • 10. Plasma norepinephrine, epinephrine, and dopamine beta-hydroxylase activity during exercise in man.
    Péronnet F, Cleroux J, Perrault H, Thibault G, Cousineau D, de Champlain J, Guilland JC, Klepping J.
    Med Sci Sports Exerc; 1985 Dec 28; 17(6):683-8. PubMed ID: 4079740
    [Abstract] [Full Text] [Related]

  • 11. Relationship to survival of catecholamine levels and dopamine-beta-hydroxylase activity in experimental haemorrhagic shock.
    Tárnoky K, Nagy S.
    Acta Physiol Hung; 1983 Dec 28; 61(1-2):59-68. PubMed ID: 6637523
    [Abstract] [Full Text] [Related]

  • 12. Hemofiltration and plasma dopamine beta-hydroxylase activity.
    Spohr U, Schneider HW, Streicher E, Schrack R, Ritz E.
    Nephron; 1980 Dec 28; 25(3):121-6. PubMed ID: 7360296
    [Abstract] [Full Text] [Related]

  • 13. Lack of correlation of plasma norepinephrine and dopamine-beta-hydroxylase in hypertensive and normotensive subjects.
    Lake CR, Ziegler MG, Coleman M, Kopin IJ.
    Circ Res; 1977 Dec 28; 41(6):865-9. PubMed ID: 923037
    [Abstract] [Full Text] [Related]

  • 14. Sympathetic activity response to changes in the intake of sodium in chronic renal failure.
    Solski J, Ksiazek A.
    Int Urol Nephrol; 1988 Dec 28; 20(5):533-8. PubMed ID: 3235304
    [Abstract] [Full Text] [Related]

  • 15. Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure.
    Ziegler MG, Kennedy B, Morrissey E, O'Connor DT.
    Kidney Int; 1990 May 28; 37(5):1357-62. PubMed ID: 2345431
    [Abstract] [Full Text] [Related]

  • 16. Catecholamines and dopamine-beta-hydroxylase activity during therapeutic abortion induced by sulprostone.
    Saarikoski S, Selander K, Nukala E, Pystynen P.
    Prostaglandins; 1980 Sep 28; 20(3):487-92. PubMed ID: 7422895
    [Abstract] [Full Text] [Related]

  • 17. [Dopamin-beta-hydroxylaseaktivität im Plasma von Dialysepatienten (author's transl)].
    Spohr U, Ritz F, Kaden F.
    Klin Wochenschr; 1977 Nov 15; 55(22):1089-93. PubMed ID: 592677
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency.
    Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS.
    Am J Med Genet; 2002 Mar 01; 108(2):140-7. PubMed ID: 11857564
    [Abstract] [Full Text] [Related]

  • 19. Plasma and lymph dopamine-beta-hydroxylase and norepinephrine during carotid occlusion.
    Velasquez MT, Alexander N.
    Am J Physiol; 1979 Jan 01; 236(1):H96-100. PubMed ID: 434180
    [Abstract] [Full Text] [Related]

  • 20. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.
    Bourdélat-Parks BN, Anderson GM, Donaldson ZR, Weiss JM, Bonsall RW, Emery MS, Liles LC, Weinshenker D.
    Psychopharmacology (Berl); 2005 Nov 01; 183(1):72-80. PubMed ID: 16163519
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.